These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 19458885)
41. Association of SNP-SNP Interactions Between RANKL, OPG, CHI3L1, and VDR Genes With Breast Cancer Risk in Egyptian Women. Shaker OG; Senousy MA Clin Breast Cancer; 2019 Feb; 19(1):e220-e238. PubMed ID: 30309792 [TBL] [Abstract][Full Text] [Related]
42. Prevalence of polymorphisms in OPG, RANKL and RANK as potential markers for Charcot arthropathy development. Bruhn-Olszewska B; Korzon-Burakowska A; Węgrzyn G; Jakóbkiewicz-Banecka J Sci Rep; 2017 Mar; 7(1):501. PubMed ID: 28356555 [TBL] [Abstract][Full Text] [Related]
43. Single nucleotide polymorphism of RANKL and OPG genes may play a role in bone and joint injury in rheumatoid arthritis. Xu S; Ma XX; Hu LW; Peng LP; Pan FM; Xu JH Clin Exp Rheumatol; 2014; 32(5):697-704. PubMed ID: 25068378 [TBL] [Abstract][Full Text] [Related]
44. Associations between HLA-DRB1, RANK, RANKL, OPG, and IL-17 genotypes and disease severity phenotypes in Japanese patients with early rheumatoid arthritis. Furuya T; Hakoda M; Ichikawa N; Higami K; Nanke Y; Yago T; Kamatani N; Kotake S Clin Rheumatol; 2007 Dec; 26(12):2137-2141. PubMed ID: 17876645 [TBL] [Abstract][Full Text] [Related]
45. Association between OPG, RANK and RANKL gene polymorphisms and susceptibility to acute coronary syndrome in Korean population. Choe WS; Kim HL; Han JK; Choi YE; Seo B; Cho HJ; Yang HK; Park KJ; Park JS; Park HJ; Kim PJ; Baek SH; Seung KB; Kim HS J Genet; 2012; 91(1):87-9. PubMed ID: 22546829 [No Abstract] [Full Text] [Related]
46. Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (review). Liu W; Zhang X Mol Med Rep; 2015 May; 11(5):3212-8. PubMed ID: 25572286 [TBL] [Abstract][Full Text] [Related]
47. Association of the A1330V and V667M polymorphisms of LRP5 with bone mineral density in Greek peri- and postmenopausal women. Markatseli AE; Hatzi E; Bouba I; Georgiou I; Challa A; Tigas S; Tsatsoulis A Maturitas; 2011 Oct; 70(2):188-93. PubMed ID: 21840657 [TBL] [Abstract][Full Text] [Related]
48. Investigation of OPG/RANK/RANKL Genes as a Genetic Marker for Cardiac abnormalities in Thalassemia Major Patients. Singh MM; Kumar R; Tewari S; Agarwal S Ann Hum Genet; 2017 May; 81(3):117-124. PubMed ID: 28244588 [TBL] [Abstract][Full Text] [Related]
49. RANKL/RANK/OPG cytokine receptor system: mRNA expression pattern in BPH, primary and metastatic prostate cancer disease. Christoph F; König F; Lebentrau S; Jandrig B; Krause H; Strenziok R; Schostak M World J Urol; 2018 Feb; 36(2):187-192. PubMed ID: 29204705 [TBL] [Abstract][Full Text] [Related]
50. Assessment and clinical implications of RANK/RANKL/OPG pathway as markers of bone tumor progression in patients with NET harboring bone metastases. Milone F; Pivonello C; Cariati F; Sarnataro M; Ramundo V; Marotta V; Jann H; Pape UF; Wiedenmann B; Colao A; Pavel M; Faggiano A Biomarkers; 2013 Mar; 18(2):121-5. PubMed ID: 23336103 [TBL] [Abstract][Full Text] [Related]
51. Genetic Risk Scores Implicated in Adult Bone Fragility Associate With Pediatric Bone Density. Mitchell JA; Chesi A; Elci O; McCormack SE; Roy SM; Kalkwarf HJ; Lappe JM; Gilsanz V; Oberfield SE; Shepherd JA; Kelly A; Grant SF; Zemel BS J Bone Miner Res; 2016 Apr; 31(4):789-95. PubMed ID: 26572781 [TBL] [Abstract][Full Text] [Related]
52. Expression of osteoprotegerin, RNAK and RANKL genes in femoral head avascular necrosis and related signaling pathway. Miao Q; Hao S; Li H; Sun F; Wang X Int J Clin Exp Pathol; 2015; 8(9):10460-7. PubMed ID: 26617755 [TBL] [Abstract][Full Text] [Related]
53. Association analyses of vitamin D-binding protein gene with compression strength index variation in Caucasian nuclear families. Xu XH; Xiong DH; Liu XG; Guo Y; Chen Y; Zhao J; Recker RR; Deng HW Osteoporos Int; 2010 Jan; 21(1):99-107. PubMed ID: 19543766 [TBL] [Abstract][Full Text] [Related]
54. Bone health in pediatric transfusion-dependent beta-thalassemia: Circulating osteoprotegerin and RANKL system. Youssry I; Saad N; Madboly M; Samy RM; Hamed ST; Tawfik H; Elbatrawy SR; Kaddah N; Abd Elaziz D Pediatr Blood Cancer; 2022 Jan; 69(1):e29377. PubMed ID: 34699125 [TBL] [Abstract][Full Text] [Related]
55. Effects of Wenyangbushen formula on the expression of VEGF, OPG, RANK and RANKL in rabbits with steroid-induced femoral head avascular necrosis. Song HM; Wei YC; Li N; Wu B; Xie N; Zhang KM; Wang SZ; Wang HM Mol Med Rep; 2015 Dec; 12(6):8155-61. PubMed ID: 26496816 [TBL] [Abstract][Full Text] [Related]
56. The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women. Zhao HY; Liu JM; Ning G; Zhao YJ; Zhang LZ; Sun LH; Xu MY; Uitterlinden AG; Chen JL Osteoporos Int; 2005 Dec; 16(12):1519-24. PubMed ID: 15782282 [TBL] [Abstract][Full Text] [Related]
57. Association of Polymorphisms in RANK and RANKL Genes with Osteopenia in Arab Postmenopausal Women. Abdi S; Bukhari I; Ansari MGA; BinBaz RA; Mohammed AK; Hussain SD; Aljohani N; Al-Daghri NM Dis Markers; 2020; 2020():1285216. PubMed ID: 33376557 [TBL] [Abstract][Full Text] [Related]
58. Expression profile of receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. Owen S; Ye L; Sanders AJ; Mason MD; Jiang WG Anticancer Res; 2013 Jan; 33(1):199-206. PubMed ID: 23267146 [TBL] [Abstract][Full Text] [Related]
59. [Cytokines in bone diseases. Genetic disorders of RANKL-RANK-OPG system]. Tokuyama N; Tanaka S Clin Calcium; 2010 Oct; 20(10):1532-8. PubMed ID: 20890036 [TBL] [Abstract][Full Text] [Related]
60. Differential expression of the RANKL/RANK/OPG system is associated with bone metastasis in human non-small cell lung cancer. Peng X; Guo W; Ren T; Lou Z; Lu X; Zhang S; Lu Q; Sun Y PLoS One; 2013; 8(3):e58361. PubMed ID: 23516466 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]